Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases
Volume 6, Suppl A, Pages 6A-10A

Transitional Antibiotic Therapy

Richard Quintiliani,1,2,3 Helen M Crowe,1,2,3 and Charles Nightingale1,2,3

1Divisions of Infectious Diseases/Allergy-Immunology, Hartford Hospital, Hartford, Canada
2University of Connecticut School of Medicine, Farmington, Canada
3University of Connecticut School of Pharmacy, Storrs, Connecticut, USA

Copyright © 1995 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


With all the fiscal restraints in healthcare systems. it is crucial to develop methods to treat infections that are both clinically sound and cost-effective. Of the various options available. the rapid transition from intravenous to oral therapy represents one of the most effective ways to attain these goals. Moreover, it has the further advantages of shortening hospital stay, reducing nosocomial bacteremia and avoiding the need to rely upon intravenous technicians and equipment. Although there is a need for more patient outcome studies with this approach, the early experience with transitional therapy appears promising.